STRATEGIC PAPER · MEDICAL AFFAIRS

Technically strong. Strategically marginalized.

Medical Affairs does not become strategic by doing more activity. It becomes strategic when it owns decisions that shape scientific authority and lifecycle value.

This paper redesigns Medical Affairs around scientific narrative ownership, evidence prioritisation and a closed insight-to-action cadence.

A hummingbird gathering nectar from tropical flowers, symbolising Medical Affairs sensing, interpreting and redistributing scientific insight across the product lifecycle.
THE REAL DIAGNOSIS

The system is built to keep the function downstream.

Medical Affairs is not failing because most professionals are weak. It is failing because technical competence is inserted into an operating model that withholds decision rights.

Governance & incentives | Commercial reporting logic

Scientific exchange is judged too close to quarterly pressure and activity volume.

Governance & incentives | Promotional budget gravity

Scientific work is funded through the wrong incentives and therefore remains vulnerable.

Capability & measurement | Convenience-filtered talent

HR rewards template-fit over strategic capability and scientific challenge.

Capability & measurement | Activity-counting culture

Visits and slides are easier to count than influence, decision quality or evidence closure.

WHAT MEDICAL AFFAIRS MUST OWN

Decision rights determine whether Medical Affairs is structurally authoritative or merely performative.

The authority model has three non-delegable components: ownership of the scientific narrative, prioritisation of evidence by decision value and governance that converts insight into action.

Medical Affairs converts governed evidence and field insight into owned scientific decisions.
THE OPERATING MODEL THAT WORKS

Three layers connect strategy to field intelligence.

Layer A: central strategy and governance

Medical strategy, evidence planning, scientific standards, training framework and impact model.

Layer B: disease and franchise pods

Medical Lead, Field Medical Lead, Evidence Lead and Scientific Communications Lead.

Layer C: field medical intelligence

MSLs as sensors, interpreters and catalysts, not slide carriers.

A forest and illuminated underground root network represent Medical Affairs connecting field insight, scientific evidence and lifecycle decisions.
STOP MEASURING WHAT IS EASY

Measure decision influence, not activity volume.

Evidence gaps closed

Scientific uncertainty reduced through owned evidence generation.

Decisions influenced

Clinical, access or lifecycle decisions changed by Medical Affairs input.

Study concepts triggered

Insights converted into testable evidence priorities.

Insight-to-action conversion

Field intelligence moved through triage, ownership, decision and execution.

WHERE MB&P FITS

A structural redesign, not a training theatre.

Operating model and decision rights

Clarify mandate, governance, interfaces and scientific authority.

Evidence strategy architecture

Connect post-launch development, integrated evidence and lifecycle decisions.

Field Medical redesign

Build competency frameworks and field intelligence systems around decision value.

Insight-to-action governance

Create the cadence that converts insight into owned, observable action.

NEXT STEP

If the organisation is technically strong but structurally marginalized, the problem is no longer training alone.

Start with four questions: who owns the scientific narrative, who prioritises evidence generation, what happens to field insight and which outcomes define credible Medical Affairs performance.